Authors: HALIASSOS A MELITAMANOLIS H AGGELAKI D TASSI D TERZOGLOU G

Citation: A. Haliassos et al., USE OF ANTI-XA ACTIVITY AS A MARKER FOR HEPARIN-INDUCED BLEEDING IN PATIENTS WITH APTT GREATER-THAN-180 S, Clinical chemistry, 43(9), 1997, pp. 1781-1782

Authors: FOSTINIS Y PAPADOPOULOS G PSARROS E MANOLOISMELITA E TERZOGLOU G HALIASSOS A

Citation: Y. Fostinis et al., IS DIRECT MEASUREMENT OF LDL GOOD ENOUGH (INVOLVEMENT OF LP(A)), Clinical chemistry, 43, 1997, pp. 719-719

Authors: MANOLIS AS VASSILIKOS V MAOUNIS TN PSARROS L MELITAMANOLIS H PAPATHEOU D HALIASSOS A CHRISTOPOULOUCOKKINOU V COKKINOS DV

Citation: As. Manolis et al., PRETREATMENT WITH ASPIRIN AND TICLOPIDINE CONFERS LOWER THROMBOGENIC POTENTIAL OF RADIOFREQUENCY CATHETER ABLATION, The American journal of cardiology, 79(4), 1997, pp. 494

Authors: HALIASSOS A LACOUAGELAKI D PSARROS E PAPADOPOULOS G FOSTINIS Y MELITAMANOLIS E

Citation: A. Haliassos et al., EVALUATION OF CARDIAC TROPONIN-I AND MASS CKMB AS MARKERS OF MYOCARDIAL INJURY IN CORONARY-ARTERY BYPASS-GRAFTING, Clinical chemistry, 42(6), 1996, pp. 120-120

Authors: HALIASSOS A PAPADOPOULOS G FOSTINIS Y PSARROS E KAPOTAS NM

Citation: A. Haliassos et al., LIS WITH PARALLEL-PROCESSING ANALYZERS AND ACCESS FROM ALL HOSPITAL TERMINALS, Clinical chemistry, 41(9), 1995, pp. 1354-1354